1. Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2

   • Theresa L. Whiteside
   • D. S. Heo
   • R. B. Herberman

   Original Articles Pages: 1 - 10

2. Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell induction

   • Soichiro Yokota
   • Takuma Shirasaka
   • Susumu Kishimoto

   Original Articles Pages: 11 - 17

3. Modification of regression of virally xenogenized tumor cells by cyclophosphamide and busulfan

   • Kiyoshi Morikawa
   • Jun-ichi Hamada
   • Hiroshi Kobayashi

   Original Articles Pages: 18 - 22

4. In vivo generation of lymphokine activated killer cell activity by ABPP and interleukin-2 and their antitumor effects against immunogenic and nonimmunogenic tumors in murine tumor models

   • Alexander M. M. Eggermont
   • Paul H. Sugarbaker
   • Johannes Jeekel

   Original Articles Pages: 23 - 30

5. Lymphocyte-induced angiogenesis factor is produced by L3T4⁺ murine T lymphocytes, and its production declines with age

   • Eldad J. Hadar
   • William B. Ershler
   • Roger G. Klopp

   Original Articles Pages: 31 - 34

6. The immunological mouse mutants nude (nu) and rhino (hr ^rh ) generate cytotoxic effector cells following adoptive immunotherapy but fail to reject a transplanted tumor

   • Robert Evans
   • Theodore M. Duffy
   • Leonard D. Shultz

   Original Articles Pages: 35 - 42

7. The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives

   • Junko Shima
   • Takayuki Yoshioka
   • Toshiyuki Hamaoka

   Original Articles Pages: 43 - 47

8. Cell-mediated immunity to chemically xenogenized tumors I. Inhibition by specific antisera and H-2 association of the novel antigens

   • Luigina Romani
   • Ursula Grohmann
   • Maria C. Fioretti

   Original Articles Pages: 48 - 54

9. Sublethal, whole-body ionizing irradiation can be tumor promotive or tumor destructive depending on the stage of development of underlying antitumor immunity

   • Michel Awwad
   • Robert J. North

   Original Articles Pages: 55 - 60

10. Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes

    • Donatella Taramelli
    • Arabella Mazzocchi
    • Giorgio Parmiani

    Original Articles Pages: 61 - 66

11. Response of natural killer cells from dietary tyrosine-and phenylalanine-restricted mice to biological response modifiers

    • Gary G. Meadows
    • Rokia M. Abdallah
    • Cheryl J. Aslakson

    Original Articles Pages: 67 - 73

12. Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactions

    • Peter C. Kohler
    • Jacquelyn A. Hank
    • Paul M. Sondel

    Original Articles Pages: 74 - 82

13. Correlation between classification of human urothelial cell lines and HLA-A,B,C expression

    • S. S. Ottesen
    • V. Tromholt
    • J. Kieler

    Original Articles Pages: 83 - 86

14. A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission

    • A. M. Liberati
    • E. Ballatori
    • F. Grignani

    Original Articles Pages: 87 - 93